
Image from insidermonkey.com
Innovate UK will invest up to £5 million in innovation projects to support the development of precision medicine (PM) technologies.
Applications can be for either feasibility study projects or industrial research and experimental development projects, although projects may have work packages in different research categories if necessary.
You must explain clearly how your proposed technology will advance precision medicine.
All projects must involve at least one UK based business.
Feasibility study projects must be led by a UK based business either:
- working alone or
- working with other businesses or research organisations
Research and development projects must:
- be collaborative and led by a UK based business of any size or research and technology organisation (RTO)
- include at least one other grant-claiming organisation, such as an NHS organisation, another healthcare provider, a business, a Catapult or other research technology organisation, a research base or a third-sector organisation
Please see below a summary of this funding opportunity:
Funding type : Grant
Project size : Feasibility study projects – up to £100,000/ Industrial research and experimental development – up to £2 million
Project dates : 1 November 2018 and up to 24 months
Deadline : 11 July 2018, 12noon
Please see this link for more information on how to apply.











3C Online Social: Thursday 26 March 1–2pm – Research Culture, Community & Can you Guess Who?
Four BU students at national midwifery conference
INRC book roundtable/presentation by Drs Jonathan Cole and Catherine Talbot, Wednesday 22/04/2026, 13:00h, P426
BU M.Res. student’s evidence to UK Parliamentary Women & Equalities Committee
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease